Linked Life Data

10110212

Source:http://linkedlifedata.com/resource/pubmed/id/10110212

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1991-5-31
pubmed:abstractText
Continuous insulin infusions are a valuable way of managing highly selected patients, although patients and healthcare practitioners must be aware of the limits and the increased risks involved with this type of technology. Maximum benefit from the CSII technology is achieved when the patient is part of a complete healthcare team accessible on a daily basis to respond to the changing nature of the underlying diabetes. Intranasal and pulmonary delivery of insulin, in contrast, represent a minor technology that will potentially add convenience to some diabetic management plans and possibly provide a new treatment approach for noninsulin-dependent diabetic patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
H
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
8755-1225
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-28
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:articleTitle
Issues in contemporary drug delivery. Part IV. Insulin therapy.
pubmed:affiliation
Philadelphia College of Pharmacy and Science, PA.
pubmed:publicationType
Journal Article, Review